Premium
Biosimilars: what are they and why do we need to know?
Author(s) -
Chaplin Steve
Publication year - 2014
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1292
Subject(s) - biosimilar , medicine , need to know , traditional medicine , intensive care medicine , computer security , computer science
As several widely used biological agents are due to come off patient the market for biosimilars is likely to grow. Here we analyse the implications for primary care